CMVLF
Price
$2.60
Change
-$0.52 (-16.67%)
Updated
Sep 2 closing price
Capitalization
263.2M
GNMSF
Price
$274.50
Change
+$15.00 (+5.78%)
Updated
Sep 5 closing price
Capitalization
16.77B
Interact to see
Advertisement

CMVLF vs GNMSF

Header iconCMVLF vs GNMSF Comparison
Open Charts CMVLF vs GNMSFBanner chart's image
Cellectis Romainville
Price$2.60
Change-$0.52 (-16.67%)
Volume$160
Capitalization263.2M
Genmab A/S
Price$274.50
Change+$15.00 (+5.78%)
Volume$3.92K
Capitalization16.77B
CMVLF vs GNMSF Comparison Chart in %
Loading...
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNMSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMVLF vs. GNMSF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMVLF is a Hold and GNMSF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CMVLF: $2.60 vs. GNMSF: $274.50)
Brand notoriety: CMVLF and GNMSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMVLF: 72% vs. GNMSF: 2669%
Market capitalization -- CMVLF: $263.2M vs. GNMSF: $16.77B
CMVLF [@Biotechnology] is valued at $263.2M. GNMSF’s [@Biotechnology] market capitalization is $16.77B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMVLF’s FA Score shows that 1 FA rating(s) are green whileGNMSF’s FA Score has 0 green FA rating(s).

  • CMVLF’s FA Score: 1 green, 4 red.
  • GNMSF’s FA Score: 0 green, 5 red.
According to our system of comparison, GNMSF is a better buy in the long-term than CMVLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMVLF’s TA Score shows that 3 TA indicator(s) are bullish while GNMSF’s TA Score has 4 bullish TA indicator(s).

  • CMVLF’s TA Score: 3 bullish, 2 bearish.
  • GNMSF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, GNMSF is a better buy in the short-term than CMVLF.

Price Growth

CMVLF (@Biotechnology) experienced а -16.67% price change this week, while GNMSF (@Biotechnology) price change was +10.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNMSF($16.8B) has a higher market cap than CMVLF($263M). CMVLF YTD gains are higher at: 73.333 vs. GNMSF (32.366). GNMSF has higher annual earnings (EBITDA): 1.48B vs. CMVLF (-30.25M). GNMSF has more cash in the bank: 2.9B vs. CMVLF (196M). CMVLF has less debt than GNMSF: CMVLF (94.8M) vs GNMSF (148M). GNMSF has higher revenues than CMVLF: GNMSF (3.26B) vs CMVLF (56.3M).
CMVLFGNMSFCMVLF / GNMSF
Capitalization263M16.8B2%
EBITDA-30.25M1.48B-2%
Gain YTD73.33332.366227%
P/E RatioN/A14.20-
Revenue56.3M3.26B2%
Total Cash196M2.9B7%
Total Debt94.8M148M64%
FUNDAMENTALS RATINGS
CMVLF vs GNMSF: Fundamental Ratings
CMVLF
GNMSF
OUTLOOK RATING
1..100
9443
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9838
PRICE GROWTH RATING
1..100
3746
P/E GROWTH RATING
1..100
10088
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMVLF's Valuation (29) in the null industry is in the same range as GNMSF (58). This means that CMVLF’s stock grew similarly to GNMSF’s over the last 12 months.

CMVLF's Profit vs Risk Rating (100) in the null industry is in the same range as GNMSF (100). This means that CMVLF’s stock grew similarly to GNMSF’s over the last 12 months.

GNMSF's SMR Rating (38) in the null industry is somewhat better than the same rating for CMVLF (98). This means that GNMSF’s stock grew somewhat faster than CMVLF’s over the last 12 months.

CMVLF's Price Growth Rating (37) in the null industry is in the same range as GNMSF (46). This means that CMVLF’s stock grew similarly to GNMSF’s over the last 12 months.

GNMSF's P/E Growth Rating (88) in the null industry is in the same range as CMVLF (100). This means that GNMSF’s stock grew similarly to CMVLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMVLFGNMSF
RSI
ODDS (%)
Bullish Trend 1 day ago
50%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
35%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
63%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
39%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
CMVLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNMSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFJIX35.53N/A
N/A
Calvert US Large Cap Value Rspnb Idx I
BSGRX14.59N/A
N/A
BlackRock Advantage Small Cap Gr R
FCAKX47.25N/A
N/A
Fidelity Capital Appreciation K
NUGCX36.70N/A
N/A
Nuveen Global Dividend Growth C
TRDIX8.47N/A
N/A
Transamerica Sustainable Equity Inc I2

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been loosely correlated with TENX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CMVLF jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
TENX - CMVLF
56%
Loosely correlated
-0.08%
SBHMY - CMVLF
51%
Loosely correlated
N/A
AURA - CMVLF
30%
Poorly correlated
+0.93%
ALDX - CMVLF
23%
Poorly correlated
+0.54%
TARS - CMVLF
23%
Poorly correlated
+0.35%
More

GNMSF and

Correlation & Price change

A.I.dvisor tells us that GNMSF and SLN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNMSF and SLN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNMSF
1D Price
Change %
GNMSF100%
+5.78%
SLN - GNMSF
24%
Poorly correlated
+8.80%
ABOS - GNMSF
20%
Poorly correlated
+4.35%
CYDY - GNMSF
14%
Poorly correlated
-1.11%
CVALF - GNMSF
9%
Poorly correlated
N/A
CMVLF - GNMSF
7%
Poorly correlated
N/A
More